WTX-212C

N/A

Report date: 2026/04/30 20:00:20

Base Information

Drug NameWTX-212C
Drug Alias NameWTX-212C
ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Somatic cell > Blood cell therapy
Mechanisms of ActionBlood cells modulators
TargetsNot applicable
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesWestlake Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesWestlake Therapeutics
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A